Review on Cardiovascular Risk Prediction
MetadataShow full item record
The objectives were to review the currently available and widely used cardiovascular risk assessment models and to examine the evidence available on new biomarkers and the nonclinical measures in improving the risk prediction in the population level. Identification of individuals at risk of cardiovascular disease (CVD), to better target prevention and treatment, has become a top research priority. Cardiovascular risk prediction has progressed with the development and refinement of risk prediction models based upon established clinical factors, and the discovery of novel biomarkers, lifestyle, and social factors may offer additional information on the risk of disease. However, a significant proportion of individuals who have a myocardial infarction still are categorized as low risk by many of the available methods. Although novel biomarkers can improve risk prediction, including B-type natriuretic peptides which have shown the best predictive capacity per unit cost, there is concern that the use of risk prediction strategies which rely upon new/or expensive biomarkers could further broaden social inequalities in CVD. In contrast, nonclinical factors such as work stress, social isolation, and early childhood experience also appear to be associated with cardiovascular risk and have the potential to be utilized for the baseline risk stratification at the population level. A stepwise approach of nonclinical methods followed by risk scores consisting of clinical risk factors may offer a better option for initial and subsequent screening, preserving more specialized approaches including novel biomarkers for enhanced risk stratification at population level in a cost-effective manner.
Showing items related by title, author, creator and subject.
Markers of inflammation associated with plaque progression and instability in patients with carotid atherosclerosisAmmirati, E.; Moroni, F.; Norata, Giuseppe; Magnoni, M.; Camici, P. (2015)Atherosclerosis is the focal expression of a systemic disease affecting medium- and large-sized arteries, in which traditional cardiovascular risk factor and immune factors play a key role. It is well accepted that ...
Smoking-associated DNA methylation biomarkers and their predictive value for all-cause and cardiovascular mortalityZhang, Y.; Schöttker, B.; Florath, Ines; Stock, C.; Butterbach, K.; Holleczek, B.; Mons, U.; Brenner, H. (2016)Background: With epigenome-wide mapping of DNA methylation, a number of novel smoking-associated loci have been identified. Objectives: We aimed to assess dose–response relationships of methylation at the top hits from ...
Clinical significance of circulating microRNAs as markers in detecting and predicting congenital heart defects in childrenSong, Y.; Higgins, H.; Guo, J.; Harrison, K.; Schultz, E.; Hales, B.; Moses, E.; Goldblatt, J.; Pachter, N.; Zhang, Guicheng (2018)Â© 2018 The Author(s). Background: Circulating microRNAs (miRNAs) are emerging as novel biomarkers for detecting cardiovascular diseases. In this study, we aimed to investigate the usefulness of miRNAs as biomarkers in ...